S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000967520.71557.f0 |
_version_ | 1797280139097145344 |
---|---|
author | Nikola Čuřík Adam Laznicka Vaclava Polivkova Jitka Křížková Pavel Semerak Eva Pokorna Pavla Suchankova Pavel Burda Andreas Hochhaus Kateřina Machová Poláková |
author_facet | Nikola Čuřík Adam Laznicka Vaclava Polivkova Jitka Křížková Pavel Semerak Eva Pokorna Pavla Suchankova Pavel Burda Andreas Hochhaus Kateřina Machová Poláková |
author_sort | Nikola Čuřík |
collection | DOAJ |
first_indexed | 2024-03-07T16:36:54Z |
format | Article |
id | doaj.art-f028e86716ee4bd0bfe0dfd27a8cb9cf |
institution | Directory Open Access Journal |
issn | 2572-9241 |
language | English |
last_indexed | 2024-03-07T16:36:54Z |
publishDate | 2023-08-01 |
publisher | Wiley |
record_format | Article |
series | HemaSphere |
spelling | doaj.art-f028e86716ee4bd0bfe0dfd27a8cb9cf2024-03-03T09:43:30ZengWileyHemaSphere2572-92412023-08-017e71557f010.1097/01.HS9.0000967520.71557.f0202308003-00054S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODELNikola Čuřík0Adam Laznicka1Vaclava Polivkova2Jitka Křížková3Pavel Semerak4Eva Pokorna5Pavla Suchankova6Pavel Burda7Andreas Hochhaus8Kateřina Machová Poláková91 Institute of Hematology and Blood Transfusion (ÚHKT), Czech Republic1 Institute of Hematology and Blood Transfusion (ÚHKT), Czech Republic1 Institute of Hematology and Blood Transfusion (ÚHKT), Czech Republic1 Institute of Hematology and Blood Transfusion (ÚHKT), Czech Republic2 2nd Medical School, Charles University, Czech Republic3 First Faculty of Medicine Charles University, Institute of Pathological Physiology, Czech Republic3 First Faculty of Medicine Charles University, Institute of Pathological Physiology, Czech Republic3 First Faculty of Medicine Charles University, Institute of Pathological Physiology, Czech Republic4 Klinik für Innere Medizin II - Hämatologie und Internistische Onkologie, Jena, Germany1 Institute of Hematology and Blood Transfusion (ÚHKT), Czech Republichttp://journals.lww.com/10.1097/01.HS9.0000967520.71557.f0 |
spellingShingle | Nikola Čuřík Adam Laznicka Vaclava Polivkova Jitka Křížková Pavel Semerak Eva Pokorna Pavla Suchankova Pavel Burda Andreas Hochhaus Kateřina Machová Poláková S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL HemaSphere |
title | S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL |
title_full | S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL |
title_fullStr | S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL |
title_full_unstemmed | S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL |
title_short | S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL |
title_sort | s152 combinatory therapy of asciminib and ponatinib was effective in the treatment of blast phase cml cdx model |
url | http://journals.lww.com/10.1097/01.HS9.0000967520.71557.f0 |
work_keys_str_mv | AT nikolacurik s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel AT adamlaznicka s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel AT vaclavapolivkova s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel AT jitkakrizkova s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel AT pavelsemerak s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel AT evapokorna s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel AT pavlasuchankova s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel AT pavelburda s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel AT andreashochhaus s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel AT katerinamachovapolakova s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel |